インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

バイオシミラー特集
バイオシミラー特集ページ バイオシミラーに関連したレポートを紹介致します。

Translational Cancer Medicine 公式サイト

Outsourcing Asia Summit 2009 公式サイト

Global Healthcare Congress 2009 公式サイト

BioMedical Asia 2009 公式サイト

China 2009 Pharmaceutical R&D Summit 公式サイト

Drug Discovery & Development of Innovative Therapeutics Japan 2009 公式サイト

World Vaccine Congress Asia 2009 公式サイト

Drug Discovery & Development of Innovative Therapeutics 2009 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

アジアにおける体外診断薬の戦略的分析

Strategic Analysis of the In Vitro Diagnostics (IVD) Markets in Asia

商品コード : 24306 Frost & Sullivan
出版日 : 2004/09
発行 : Frost & Sullivan
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Research Overview

Emerging Asian Economies Provide Growth Opportunities to IVD Market Participants

In vitro diagnostics (IVD) is one of the most exciting segments in global healthcare and the Asian IVD markets have been expanding at a double-digit rate. This growth is propelled by increased affluence, awareness, and spending on healthcare in this region. While the swelling Asian economies continue to fuel demand for IVD, participants in this market must overcome challenges related to distribution channels, intellectual property protection, and a strong local industry to achieve optimum market development.

Frost & Sullivans recent strategic analysis of the Asian IVD market offers in-depth information about the total Asian market along with an overview of the clinical chemistry, microbiology, hematology, point of care (POC), coagulation, molecular biology, and immunoassay segments.

Ageing Population and Mounting Government Measures Stimulate Market Growth

Asian governments are under increased pressure to provide elderly populations - which are expected to double in the near future - with adequate healthcare. "The desire of the ageing population to remain healthy and active is a leading market driver," says the analyst of this research. "For instance, with over 20 percent of the Japanese population above the age of 65 and a decreasing productive population:elderly population ratio, the Japanese government is under tremendous pressure to reduce costs for healthcare facilities."

Governments are also imposing stricter disease control measures, motivating market growth and demand, as well as creating a positive impact on the IVD market. The move toward integrated healthcare, especially with the consistent shift toward proactive testing rather reactive testing, is also expected to propel IVD markets.

Rising Demand for High Quality Healthcare

As Asian economies grow, their populations with increased average life expectancies have also been rising. This creates a requirement for access to quality healthcare.

"As citizens capable of accessing superior healthcare facilities are expected to double in the near future in countries such as China and India, participants must effectively exploit the increased opportunities for revenue increase," says the analyst. "Private insurance companies are gradually intensifying efforts to promote healthcare coverage in the Asian IVD market, which again drives demand since patients having less out-of-pocket expenses."

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivans GPS includes:

  • Assisting companies to reach their full potential in the core business
  • Providing growth strategies to help companies expand into related businesses
  • Preemptively redefining the core business during market turbulence
  • Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
  • Recommending growth management strategies through continuous partnership

To maximize the potential for growth within a firms internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivans strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients growth.

1 STRATEGIC ANALYSIS OF ASIAN IVD MARKETS

  • Overview
    • Overview
  • Research Scope and Methodology
    • Research Scope and Methodology
  • Introduction and Background to Asian IVD Market
    • Market Segmentation
    • Glossary and exchange rates
  • Market Overview
    • Introduction
    • Main Applications of IVDs
    • Market Challenges
    • Key Drivers
    • Proportion of population above 65 years
    • Key Restraints
    • Per capita healthcare expenditure
    • Strategic Recommendations
    • Key Strategies
  • Market Dynamics
    • Key Trends
    • Customer Priorities Trajectory
    • Pricing Trends
    • Geographic Analysis
  • Market Forecasts
    • Assumptions
    • Key Market Engineering Measurements
    • Market Attractiveness
    • Total Market Revenue
    • Revenue Sectorial Analysis
    • Total Market Competitive Landscape
    • Top 10 IVD Companies
    • Company Profiles
    • Clinical Chemistry Test Market: Revenue Forecasts
    • Coagulation Test Market: Revenue Forecasts
    • Hematology Test Market: Revenue Forecasts
    • Immunoassay Test Market: Revenue Forecasts
    • Microbiology Test Market: Revenue Forecasts
    • Molecular Biology Test Market: Revenue Forecasts
    • POC Test Market: Revenue Forecasts
  • Frost & Sullivan Awards
    • Frost & Sullivan Awards
    • Technology Innovation Award
    • Business Development Strategy Leadership Award
    • Product Line Strategy Leadership Award
    • Market Leadership Award
    • Technology Leadership Award
  • Industry Participants
    • Industry Participants
  • Decision Support Database
    • Decision Support Databases
  • About Frost & Sullivan
    • Healthcare Team
    • Our Capabilities
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
アジアにおける体外診断薬の戦略的分析
Strategic Analysis of the In Vitro Diagnostics (IVD) Markets in Asia
出版日 : 2004/09
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、為替レート (TTS: 93.56) 換算による円建てのご請求書にて承ります。

US $ 5,450 換算 -> ¥ 509,902 (税抜) Hard Copy & Web Access (Regional License)
US $ 4,950 換算 -> ¥ 463,122 (税抜) Web Access
商品コード : 24306